NFKB1 and neoplasm: For example, both CXCL8 and CCL2 promote the production of inflammatory mediators and the recruitment of immune cells through the activation of the NF-κB pathway, which enhances the inflammatory microenvironment of tumors and the resistance of tumor cells to apoptosis [27,28].